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Background
The mammalian target of rapamycin (mTOR) has been
shown to regulate rates of muscle protein synthesis, and
one novel nutritional activator of mTOR is the phospho-
lipid Phosphatidic Acid (PA). We have recently found
that PA supplementation over 8 weeks of resistance train-
ing augmented responses in skeletal muscle hypertrophy
and strength. However, we are unaware of research inves-
tigating the safety of PA in human subjects. Therefore
the purpose of this study was to investigate the effects of
8 weeks of 750 mg per day of PA supplementation on
safety parameters in healthy college aged males.
Methods
Twenty-eight healthy, college aged male subjects (21 ± 3
years of age, bodyweight of 76 ± 9 kg, and height of
176 cm ± 9 cm) participated in this study. Subjects were
equally divided into experimental and control conditions.
The experimental condition (EXP) received 750 mg
of soy-derived PA (Mediator™, Chemi Nutra, White Bear
Lake, MN), while the control condition (CON) received
a visually identical placebo (rice flour). Measures of cardio-
vascular, kidney, and liver function were analyzed with
a full CMP and CBC prior to and 8 weeks following
supplementation. This analysis included: total, high
density, and low density lipoproteins, blood glucose, blood
urea nitrogen, creatinine, eGFR, Na, K, Cl, CO2, Ca,
protein, albumin, globulin, albumin:globulin ratio, total
bilirubin, alkaline phosphatase, aspartate aminotransferase,
and alanine aminotransferase. In addition a sample of
urine was submitted for analysis of urine specific gravity
and pH. A 2x2 repeated measures ANOVA was used to
determine group, time, and group x time interactions.
A Tukey post-hoc was used to locate differences.
Results
There were no differences at baseline in blood chemistry
and hematology between the CON and EXP supplemented
groups. Additionally no differences were observed in
urinalysis values between the groups. Moreover no group,
or group X time effects were found following 8 weeks of
supplementation.
Conclusions
Soy-derived PA is a safe nutritional supplement for healthy
college aged subjects if taken up to a dosage of 750 mg
over an eight week period.
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